openPR Logo
Press release

Feed Enzyme Market is Driven by the Increasing Demand for Animal-based Products

10-21-2020 11:52 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Markets and Markets

The Feed Enzymes Market by Type (Phytase, Carbohydrase, and Protease), Livestock (Poultry, Swine, Ruminants, and Aquatic Animals), Source (Microorganism, Plant, and Animal), Form (Dry and Liquid), and Region – Global Forecast to 2025", size is projected to reach USD 1.9 billion by 2025, which was estimated at USD 1.3 billion in 2020; it is expected to grow at a CAGR of 8.1% from 2020. One of the major factors driving the feed enzyme industry is the provision of cost-efficiency in the use of feed. Also, the increasing demand for animal-based products, such as meat products, dairy products, and eggs, and the rise in the global demand for naturally produced feed additives have been driving the growth of this market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1157

The feed enzymes market includes major Tier I and II suppliers like BASF SE, DowDu Pont, Koninklijke DSM N.V, Bluestar Adisseo, and Kemin Industries. These suppliers have their manufacturing facilities spread across various countries across Asia Pacific, Europe, North America, South America, and RoW. Though COVID-19 has impacted their businesses as well, there is no significant impact on the global operations and supply chain of their feed enzymes. Multiple manufacturing facilities of players are still in operation. The international trade barriers, closure of restaurants, hotels, and live animal markets, supply chain hindrances, consumption patterns of livestock-based products were considered to be mildly significant, which has disrupted the market for feed enzymes. However, the demand for feed enzymes in the livestock industry is likely to increase in the first and second quarters of the year 2020 as many farmers resorted to panic buying of feed additives in anticipation of potential shortages.

Phytases are digestive enzymes that release plant phosphorus from phytic acid; monogastric animals, such as poultry birds, lack sufficient phytases to release this phosphorus. Adding extra phytases to the diet increases phytate breakdown and consequent utilization of plant phosphorus. According to DuPont, one of the major feed enzyme manufacturers, phytases are the most widely used type of feed enzymes in the world, included in 90% of poultry and 70% of swine diets. This segment accounted for the highest share in 2020 at a global level. Thus, increasing phytic acid degradation and the need to improve the availability of plant phosphorus could offer major benefits for poultry and swine producers, including lower levels of inorganic phosphorus inclusion in diets, reduced feed costs, and better sustainability of animal production.

The poultry segment is projected to grow at the highest rate during the forecast period since there is intensive usage of feed enzymes in the broiler feed, which influences high tender meat production. Poultry does not produce enzymes for hydrolysis of non-starch polysaccharide present in the cell wall of grains, and they remain un-hydrolyzed. This results in low feed efficiency. Feed enzymes break down the NSPs, decrease intestinal viscosity, and eventually improve the digestibility of nutrients by improving gut performance. Poultry in the Asia Pacific region is also witnessing an ever-increasing demand, as consumers are adding white meat instead of red meat to their diets. Additionally, poultry population growth, which has doubled in the last two decades, according to the Food and Agriculture Organization of the United Nations (FAO), is supporting the high growth rate of the poultry segment.

Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=1157

Asia Pacific dominated the global feed enzymes market in 2019; this has been supported by the presence of a large livestock population (FAO 2016) and the growth rate. Also, livestock producers in China and India are focusing on animal health by resorting to natural solutions.

Additionally, there has been a rise in the demand for meat and meat products, in accordance with the need for a protein-rich meat diet. The market for poultry is estimated to increase in India and China due to factors such as the focus on meat quality and public health campaigns, which encourage the consumption of lower-fat protein options. Fish consumption is also increasing in the region owing to similar health trends. On the other hand, there has been an increase in production as well as consumption of dairy products in the region. These factors are expected to drive the feed enzymes market in the Asia Pacific region.

The major vendors in the global feed enzyme market are BASF SE (Germany), DowDu Pont (US), Koninklijke DSM N.V (Netherlands), Bluestar Adisseo (China), and Kemin Industries (US).

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Feed Enzyme Market is Driven by the Increasing Demand for Animal-based Products here

News-ID: 2166647 • Views:

More Releases from Markets and Markets

Controlled-release Fertilizers Market Latest Trends, Demands, Overview and Analysis by 2028
Controlled-release Fertilizers Market Latest Trends, Demands, Overview and Analy …
The controlled-release fertilizers market is experiencing notable growth, estimated at USD 2.2 billion in 2023 and projected to reach USD 2.9 billion by 2028. This reflects a compound annual growth rate (CAGR) of 5.9% during the forecast period. The demand for controlled-release fertilizers is increasing due to their benefits in enhancing nutrient efficiency, reducing environmental impact, and supporting sustainable agricultural practices. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=136099624 These fertilizers are prized for their ability
Gelatin Market is Projected to Reach $5.6 billion by 2029, at a CAGR of 6.9% from 2024 to 2029
Gelatin Market is Projected to Reach $5.6 billion by 2029, at a CAGR of 6.9% fro …
According to a research report titled "Gelatin Market by Source (Animal, Plants), By Applications (Food & Beverages, Pharmaceuticals, Health & Nutrition, Cosmetics, Personal Care, Animal Feed), Type (Type A, Type B), Function (Thickener, Stabilizer, Gelling Agent) - Global Forecast to 2029," published by MarketsandMarkets, the gelatin market is poised for significant growth. The market, valued at USD 4.0 billion in 2024, is projected to reach USD 5.6 billion by 2029,
Facility Management Market Status, Revenue, Growth Rate, Services and Solutions
Facility Management Market Status, Revenue, Growth Rate, Services and Solutions
According to a research report "Facility Management Market by Offering (Solutions (IWMS, BIM, Facility Operations & Security Management) and Services), Vertical (BFSI, Retail, Construction & Real Estate, Healthcare & Life sciences) and Region - Global Forecast to 2028" published by MarketsandMarkets, the facility management market is estimated at USD 49.6 billion in 2023 to USD 94.8 billion by 2028, at a Compound Annual Growth Rate (CAGR) of 13.8%. Download PDF Brochure:
Endpoint Security Market Size, Revenue, Growth Rate Analysis and Forecast 2024
Endpoint Security Market Size, Revenue, Growth Rate Analysis and Forecast 2024
According to a research report "Endpoint Security Market by Solution (Endpoint Protection Platform and Endpoint Detection and Response), Service, Deployment Mode, Organization Size, Vertical (Healthcare, Retail and eCommerce, and Government), and Region - Global Forecast to 2024", published by MarketsandMarkets, the global endpoint security market size is expected to grow from USD 12.8 billion in 2019 to USD 18.4 billion by 2024, at a Compound Annual Growth Rate (CAGR) of

All 5 Releases


More Releases for MarketsandMarkets™

Biomaterials Market Worth $64.2 billion | MarketsandMarkets™
Biomaterials Market in terms of revenue was estimated to be worth $45.2 billion in 2024 and is poised to reach $64.2 billion by 2029, growing at a CAGR of 7.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. The biomaterials market is estimated to grow at a CAGR of 7.3% during the forecast period of 2024 to 2029. The important factors impacting market growth are the growing
Cell Expansion Market Worth $26.7 billion | MarketsandMarkets™
Cell Expansion Market in terms of revenue was estimated to be worth $14.3 billion in 2024 and is poised to reach $26.7 billion by 2029, growing at a CAGR of 13.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. Some factors contributing to the growth of the global market includes increasing R&D investments in cell based research, growing focus on personalized medicine, and increasing number of strategic
Apheresis Market Worth $3.9 billion | MarketsandMarkets™
Apheresis Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 8.8% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the apheresis market is driven by rise in demand for source plasma from biopharmaceutical companies, upsurging demand for blood components and favourable reimbursement for apheresis. The increasing
Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.
Pipette Calibrators Market Worth $391 million | MarketsandMarkets™
Pipette Calibrators Market in terms of revenue was estimated to be worth $286 million in 2024 and is poised to reach $391 million by 2029, growing at a CAGR of 6.5% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by rise in genomics and proteomics research, growth in portable and handheld devices, and establishment of new research facilities by pharmaceutical
Mice Model Market Worth $2.2 billion | MarketsandMarkets™
Mice Model Market in terms of revenue was estimated to be worth $1.5 billion in 2024 and is poised to reach $2.2 billion by 2029, growing at a CAGR of 8.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The rise in chronic diseases, such as cancer, diabetes, and cardiovascular disorders, and growing need for reliable and predictive animal models to facilitate drug discovery and development are